Alexandra Bekiaridou

Dr. Alexandra Bekiaridou


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAlexandra Bekiaridou
Alexandra Bekiaridou
Athanasios SamarasAthanasios Samaras
Athanasios Samaras
AKAnastasios Kartas
Anastasios Kartas
APAndreas S. Papazoglou
Andreas S. Papazoglou
Dimitrios V. MoysidisDimitrios V. Moysidis
Dimitrios V. Moysidis
ATApostolos Tzikas
Apostolos Tzikas
Background: There is limited “real-world” data on the prognostic role of gender in comorbid atrial fibrillation (AF) and coronary artery disease (CAD). Methods: In this post-hoc analysis of the MISOAC-AF randomized trial (NCT: 02941978), consecutive patients with AF and CAD who were discharged from the cardiology ward between 2015 and 2018 were included. Multivariable Cox-regression analysis was performed for all-cause mortality and cardiovascular (CV) mortality. Competing-risk analysis was performed for the outcomes of stroke or systemic embolism, major bleeding, AF- or heart failure (HF)-related hospitalization, adjusted for the competing risk of all-cause death. Results: Of 1098 patients with AF, 461 patients with comorbid CAD were analyzed. Women were older and more likely to have a history of diabetes mellitus and valvular heart disease, while men were more likely to have a history of smoking or myocardial infarction. Over a median follow-up of 31 months, 143 (43.4%) men and 71 (53.7%) women died. Women were at a higher risk for all-cause mortality (adjusted hazard ration [aHR] 1.65; 95% confidence interval [CI] 1.14–2.38) and stroke or systemic embolism (aHR 3.52; 95% CI 1.46–8.49) compared to men. The risks of CV mortality, major bleeding, AF-related hospitalization, and HF-related hospitalization were similar between genders. Conclusions: In recently hospitalized patients with AF and comorbid CAD, the female gender was independently associated with increased all-cause mortality and thromboembolic events.

22 August 2024
Verified
Book Chapter
Closed access
PDF file
AFAlexei Figueroa
Alexei Figueroa
JPJens-Michalis Papaioannou
Jens-Michalis Papaioannou
CFConor Fallon
Conor Fallon
ABAlexandra Bekiaridou
Alexandra Bekiaridou
KBKeno Bressem
Keno Bressem
ALAlexander Löser
Alexander Löser